Conopeptides: From deadly venoms to novel therapeutics

Drug Discovery Today

Volumn 5, Issue 3, 2000, Pages 98-106

  Shen, Gregory S ^a   Layer, Richard T ^a   McCabe, R Tyler ^a  

^a Cognetix ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CONOPEPTIDE; ALPHA CONOPEPTIDE IMI; ALPHA CONOPEPTIDE MII; ALPHA CONOPEPTIDE PNIA; ALPHA CONOPEPTIDE PNIB; BROMOCONTRYPHAN; CONANTOKIN; CONANTOKIN G; CONANTOKIN R; CONOPEPTIDE; CONOPRESSIN; CONOTOXIN; CONTRYPHAN; CONTRYPHAN R; KAPPA CONOPEPTIDE; MU CONOPEPTIDE; MU CONOPEPTIDE GIIIA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NATURAL PRODUCT; OMEGA CONOPEPTIDE GVIIA; OMEGA CONOPEPTIDE MVIIB; OMEGA CONOPEPTIDE MVIID; OMEGA CONOPEPTIDE SVIA; OMEGA CONOTOXIN; OMEGA CONOTOXIN GVIA; OMEGA CONOTOXIN MVIIA; OMEGA CONOTOXIN MVIIC; UNCLASSIFIED DRUG; VENOM;

ANALGESIC ACTIVITY; ANTICONVULSANT ACTIVITY; CHRONIC PAIN; CLINICAL TRIAL; CONTROLLED DRUG RELEASE; DRUG CLASSIFICATION; DRUG DELIVERY SYSTEM; DRUG INDICATION; DRUG MECHANISM; DRUG SELECTIVITY; DRUG STRUCTURE; HUMAN; INFUSION PUMP; NONHUMAN; REVIEW; SEIZURE; SNAIL; STRUCTURE ACTIVITY RELATION;

EID: 0033997841     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(99)01454-3     Document Type: Review

References (61)

1. Tallman, J. (1999) Neuropsychopharmacology at the new millennium: New industry directions. Neuropsychopharmacology 20, 99-105
2. + channel α-subunit in hyperkalaemic periodic paralysis, Nature 354, 387-389
3. Splawski, I. et al. (1997) Molecular basis of the long-QT syndrome associated with deafness. New Engl. J. Med. 336, 1562-1567
4. 2+ channel gene CACNL1A4. Cell 87, 543-552
5. Holladay, M.W. et al. (1998) Identification and initial structure-activity relationships of (R)-5-(2-azetidinylmethoxy)-2-chloropyridine (ABT-594), a potent, orally active, non-opiate analgesic agent acting via neuronal nicotinic acetylcholine receptors. J. Med. Chem. 41, 407-412
6. Kraft, A.S. et al. (1996) Comparison of the antitumor activity of bryostatins 1, 5, and 8. Cancer Chemother. Pharmacol. 37, 271-278
7. Pettit, G.R. et al. (1998) Antineoplastic agents 365. Dolastatin 10 SAR probes. Anticancer Drug Des. 13, 243-277
8. Scheid, C. et al. (1994) Immunomodulation in patients receiving intravenous Bryostatin 1 in a Phase I clinical study: Comparison with effects of Bryostatin 1 on lymphocyte function in vitro. Cancer Immunol. Immunother. 39, 223-230
9. Zewail-Foote, M. and Hurley, L.H. (1999) Ecteinascidin 743: A minor groove alkylator that bends DNA toward the major groove. J. Med. Chem. 42, 2493-2497
10. Olivera, B. et al. (1988) Marine snail venoms. In Handbook of Natural Toxins (Tu, A., ed.), pp. 327-350, Marcel Dekker
11. Olivera, B.M. et al. (1999) Speciation of cone snails and interspecific hyperdivergence of their venom peptides. Potential evolutionary significance of introns. Ann. New York Acad. Sci. 870, 223-237
12. Duda, T.F., Jr. and Palumbi, S.R. (1999) Molecular genetics of ecological diversification: Duplication and rapid evolution of toxin genes of the venomous gastropod Conus. Proc. Natl. Acad. Sci. U. S. A. 96, 6820-6823
13. McIntosh, M. et al. (1982) Isolation and structure of a peptide toxin from the marine snail Conus magus. Arch. Biochem. Biophys. 218, 329-334
14. Shon, K.J. et al. (1997) A noncompetitive peptide inhibitor of the nicotinic acetylcholine receptor from Conus purpurascens venom. Biochemistry 36, 9581-9587
15. Rivier, J. et al. (1987) Total synthesis and further characterization of the γ-carboxyglutamate-containing 'sleeper' peptide from Conus geographus venom. Biochemistry 26, 8508-8512
16. Mena, E.E. et al. (1990) Conantokin-G: A novel peptide antagonist to the N-methyl-D-aspartic acid (NMDA) receptor. Neurosci. Lett. 118, 241-244
17. Jimenez, E.C. et al. (1996) Contryphan is a D-tryptophan-containing Conus peptide. J. Biol. Chem. 271, 28002-28005
18. Cartier, G.E. et al. (1996) A new α-conotoxin which targets α3β2 nicotinic acetylcholine receptors. J. Biol. Chem. 271, 7522-7528
19. Gray, W.R. et al. (1984) Conotoxin GI: Disulfide bridges, synthesis, and preparation of iodinated derivatives. Biochemistry 23, 2796-2802
20. Yoshikami, D. et al. (1989) The inhibitory effects of ω-conotoxins on Ca channels and synapses. Ann. New York Acad. Sci. 560, 230-248
21. Cruz, L.J. et al. (1989) μ-Conotoxin GIIIA, a peptide ligand for muscle sodium channels: Chemical synthesis, radiolabeling, and receptor characterization. Biochemistry 28, 3437-3442
22. Shon, K.J. et al. (1997) Three-dimensional solution structure of α-conotoxin Mil, an α3β2 neuronal nicotinic acetylcholine receptor-targeted ligand. Biochemistry 36, 15693-15700
23. Hu, S.H. et al. (1997) Crystal structure at 1.1 A resolution of α-conotoxin PnIB: Comparison with α-conotoxins PnIA and GI. Biochemistry 36, 11323-11330
24. Rigby, A.C. et al. (1997) Three-dimensional structure of a γ-carboxyglutamic acid-containing conotoxin, conantokin G, from the marine snail Conus geographus: The metal-free conformer. Biochemistry 36, 6906-6914
25. Rogers, J.P. et al. (1999) NMR solution structure of α-conotoxin ImI and comparison to other conotoxins specific for neuronal nicotinic acetylcholine receptors. Biochemistry 58, 3874-3882
26. Quiram, P.A. et al. (1999) Pairwise interactions between neuronal α7 acetylcholine receptors and α-conotoxin ImI. J. Biol. Chem. 274, 19517-19524
27. Quiram, P.A. and Sine, S.M. (1998) Structural elements in α-conotoxin ImI essential for binding to neuronal α7 receptors. J. Biol. Chem. 273, 11007-11011
28. 1H nuclear magnetic resonance. J. Med. Chem. 42, 2364-2372
29. Skjaerbaek, N. et al. (1997) Determination of the solution structures of conantokin-G and conantokin-T by CD and NMR spectroscopy. J. Biol. Chem. 272, 2291-2299
30. Skolnick, P. et al. (1994) Conantokin-G and its analogs: Novel probes of the NMDA receptor-associated polyamine site. In Pharmacology and Toxicology: Basic and Clinical Aspects: Direct and Allosteric Control of Glutamate Receptors (Palfreyman, M. et al., eds), pp. 155-165, CRC Press
31. Haack, J.A. et al. (1993) Conantokin-G antagonism of the NMDA receptor subtype expressed in cultured cerebellar granule cells. Neurosci. Lett. 163, 63-66
32. Skolnick, P. et al. (1992) Noncompetitive inhibition of N-methyl-D-aspartate by conantokin-G: Evidence for an allosteric interaction at polyamine sites. J. Neurochem. 59, 1516-1521
33. Huang, C.C. et al. (1997) Conantokin-T selectively antagonizes N-methyl-D-aspartate-evoked responses in rat hippocampal slice. Toxicon 35, 355-363
34. Hammerland, L.G. et al. (1992) Conantokin-G selectively inhibits N-methyl-D-aspartate-induced currents in Xenopus oocytes injected with mouse brain mRNA. Eur. J. Pharmacol. 226, 239-244
35. Chandler, P. et al. (1993) Polyamine-like actions of peptides derived from conantokin-G, an N-methyl-D-aspartate (NMDA) antagonist. J. Biol. Chem. 268, 17173-17178
36. Olivera, B.M. et al. (1994) Calcium channel diversity and neurotransmitter release: The ω-conotoxins and ω-agatoxins. Ann. Rev. Biochem. 63, 823-867
37. Nielsen, K.J. et al. (1996) A consensus structure for ω-conotoxins with different selectivities for voltage-sensitive calcium channel subtypes: Comparison of MVIIA, SVIB and SNX-202. J. Mol Biol. 263, 297-310
38. 1H-NMR of ω-conotoxin MVIID, a calcium channel blocker peptide. Biochem. Biophys. Res. Commun. 254, 32-35
39. Kerr, L.M. and Yoshikami, D. (1984) A venom peptide with a novel presynaptic blocking action. Nature 308, 282-284
40. Malmberg, A.B. and Yaksh, T.L. (1994) Voltage-sensitive calcium channels in spinal nociceptive processing: Blockade of N- and P-type channels inhibits formalin-induced nociception. J. Neurosci. 14, 4882-4890
41. Chaplan, S.R. et al. (1994) Role of voltage-dependent calcium channel subtypes in experimental tactile allodynia. J. Pharmacol. Exp. Ther. 269, 1117-1123
42. Bowersox, S.S. et al. (1996) Selective N-type neuronal voltage-sensitive calcium channel blocker, SNX-111, produces spinal antinociception in rat models of acute, persistent and neuropathic pain. J. Pharmacol. Exp. Ther. 279, 1243-1249
43. Xiao, W.H. and Bennett, G.J. (1995) Synthetic ω-conopeptides applied to the site of nerve injury suppress neuropathic pains in rats. J. Pharmacol. Exp. Ther. 274, 666-672
44. White, D.M. and Cousins, M.J. (1998) Effect of subcutaneous administration of calcium channel blockers on nerve injury-induced hyperalgesia. Brain Res. 801, 50-58
45. Yamamoto, T. and Sakashita, Y. (1998) Differential effects of intrathecally administered N- and P-type voltage-sensitive calcium channel blockers upon two models of experimental mononeuropathy in the rat. Brain Res. 794, 329-332
46. Sluka, K.A. (1998) Blockade of N- and P/Q-type calcium channels reduces the secondary heat hyperalgesia induced by acute inflammation. J. Pharmacol. Exp. Ther. 287, 232-237
47. Heading, C. (1999) Ziconotide. Curr. Opin. CPNS Invest. Drugs 1, 153-166
48. Haack, J.A. et al. (1990) Conantokin-T. A γ-carboxyglutamate containing peptide with N-methyl-D-aspartate antagonist activity. J. Biol. Chem. 265, 6025-6029
49. Craig, A.C. et al. (1999) Contulakin-G, an O-glycosylated invertebrate neurotensin. J. Biol. Chem. 274, 13752-13759
50. Craig, A.G. et al. (1998) An O-Glycosylated neuroexcitatory Conus peptide. Biochemistry 37, 16019-16025
51. Craig, A.G. et al. (1997) A novel post-translational modification involving bromination of tryptophan. Identification of the residue, L-6-bromotryptophan, in peptides from Conus imperialis and Conus radiatus venom. J. Biol. Chem. 272, 4689-4698
52. Jimenez, E.C. et al. (1997) Bromocontryphan: Post-translational bromination of tryptophan. Biochemistry 36, 989-994
53. 2+ influx. Proc. Natl. Acad. Sci. U. S. A. 96, 5758-5763
54. Cruz, L.J. et al. (1985) Conus geographies toxins that discriminate between neuronal and muscle sodium channels. J. Biol. Chem. 260, 9280-9288
55. McIntosh, J.M. et al. (1994) A nicotinic acetylcholine receptor ligand of unique specificity, α-conotoxin ImI. J. Biol. Chem. 269, 16733-16739
56. Codignola, A. et al. (1996) α-Conotoxin imperialis I inhibits nicotine-evoked hormone release and cell proliferation in human neuroendocrine carcinoma cells. Neurosci. Lett. 206, 53-56
57. McIntosh, J.M. et al. (1995) A new family of conotoxins that blocks voltage-gated sodium channels. J. Biol. Chem. 270, 16796-16802
58. + channel. J. Biol. Chem. 273, 33-38
59. Cruz, L.J. et al. (1987) Invertebrate vasopressin/oxytocin homologs. Characterization of peptides from Conus geographus and Conus straitus venoms. J. Biol. Chem. 262, 15821-15824
60. Norton, R. and Pallaghy, P. (1998) The cystine knot structure of ion channel toxins and related polypeptides. Toxicon 36, 1573-1583
61. Holladay, M.W. et al. (1997) Neuronal nicotinic acetylcholine receptors as targets for drug discovery. J. Med. Chem. 40, 4169-4194